Grant Holder |
Current project Institute Amount Awarded Duration Type of Award |
Dual targeting of MUC1 and ErbB2 in the adoptive immunotherapy of breast cancer
Dr Maher’s work is focused on developing new types of breast cancer treatments that harnesses the power of the body’s own immune system.
With this three-year project grant Dr Maher hopes to develop a unique way of treating breast cancer.